Insmed (INSM) Enterprise Value (2010 - 2026)
Insmed (INSM) recorded quarterly Enterprise Value of -$1.2 billion in Q1 2026, up 14.44% quarter-over-quarter from -$1.4 billion in Q4 2025, and down 2.01% on a YoY basis from -$1.2 billion in Q1 2025.
Insmed (INSM) Enterprise Value (2010 - 2026) Analysis & Trends
Insmed's Enterprise Value history runs 17 years deep, the most recent figure standing at -$1.2 billion for Q1 2026.
- In Q1 2026, Enterprise Value fell 2.01% year-over-year to -$1.2 billion; the TTM figure through Mar 2026 stood at -$1.2 billion (down 2.01% YoY), while the FY2025 annual figure was -$1.4 billion, changed 0.26% from the prior year.
- Enterprise Value was -$1.2 billion for Q1 2026 at Insmed, up from -$1.4 billion in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$513.3 million in Q3 2022 to a low of -$1.9 billion in Q2 2025.
- Historically, Enterprise Value has averaged -$1.1 billion across 5 years, with a median of -$1.1 billion in 2022.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value soared 40.35% in 2024, then plunged 101.34% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$1.1 billion in 2022, then jumped by 32.03% to -$780.4 million in 2023, then sank by 83.72% to -$1.4 billion in 2024, then rose by 0.26% to -$1.4 billion in 2025, then advanced by 14.44% to -$1.2 billion in 2026.
- The last three Enterprise Value figures came in at -$1.2 billion (Q1 2026), -$1.4 billion (Q4 2025), and -$1.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -584.73 Mn |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | -1.22 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.22 Bn |
| Dec 31, 2025 | -1.43 Bn |
| Sep 30, 2025 | -1.68 Bn |
| Jun 30, 2025 | -1.86 Bn |
| Mar 31, 2025 | -1.20 Bn |
| Dec 31, 2024 | -1.43 Bn |
| Sep 30, 2024 | -1.47 Bn |
| Jun 30, 2024 | -1.25 Bn |
| Mar 31, 2024 | -595.73 Mn |
| Dec 31, 2023 | -780.45 Mn |
| Sep 30, 2023 | -785.94 Mn |
| Jun 30, 2023 | -917.77 Mn |
| Mar 31, 2023 | -998.68 Mn |
| Dec 31, 2022 | -1.15 Bn |
| Sep 30, 2022 | -513.26 Mn |
| Jun 30, 2022 | -554.89 Mn |
| Mar 31, 2022 | -635.12 Mn |
| Dec 31, 2021 | -716.78 Mn |
| Sep 30, 2021 | -846.60 Mn |
| Jun 30, 2021 | -928.33 Mn |